Alginate rafts and their characterisation

International Journal of Pharmaceutics

Volumn 294, Issue 1-2, 2005, Pages 137-147

  Hampson, F C ^a   Farndale, A ^a   Strugala, V ^a   Sykes, J ^a   Jolliffe, I G ^a   Dettmar, P W ^a  

^a RECKITT BENCKISER   (United Kingdom)

Author keywords

Alginate; Formulation; Gastro oesophageal reflux; Raft

Indexed keywords

ALGICON; ALGINIC ACID; ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; BICARBONATE; CALCIUM BICARBONATE; CALCIUM DERIVATIVE; CALCIUM ION; CARBON DIOXIDE; GAVISCON; MAGNESIUM ALGINATE; MAGNESIUM CARBONATE; MAGNESIUM DERIVATIVE; MAGNESIUM TRISILICATE; MYLANTA; PEPTAC; POTASSIUM CARBONATE; RENNIE DUO; UNCLASSIFIED DRUG;

ARTICLE; GASTROINTESTINAL REFLUX; GEL; IONIC STRENGTH; LIQUID; MODEL; PRECIPITATION; PRIORITY JOURNAL; STOMACH ACID;

EID: 16244407384     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.01.036     Document Type: Article

References (25)

1. J.L. Bryan, S.L. Little, J. Sykes, T. Baxter, and P.W. Dettmar Efficacy and safety of a unique anti-reflux agent, Gaviscon Advance for the treatment of heartburn in pregnancy Gastroenterology 120 2001 A434
2. B. Chevrel A comparative cross-over study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium-aluminium antacid gel J. Int. Med. Res. 8 1980 300 302
3. W.J. Dodds, J. Dent, W.J. Hogan, J.F. Helm, R. Hauser, G.K. Patel, and M.S. Egide Mechanisms of gastroesophageal reflux in patients with reflux esophagitis New Engl. J. Med. 307 1982 1547 1552
4. H. Ertesvåg, S. Valla, and G. Skjak-Braek Genetics and biosynthesis of alginates Carbohydr. Eur. 14 1996 14 18
5. J.S. Goodall, J.M. Orwin, and M.J. Imrie A combined pH and X-ray study of a liquid alginate/antacid formulation using a novel X-ray contrast medium Acta Therap. 3 1977 141 153
6. A. Haug, B. Larsen, and O. Smidsrod Uronic acid sequence in alginate from different sources Carbohydr. Res. 32 1974 217 225
7. I.G. Jolliffe, F.C. Hampson, R. Campbell, and P.W. Dettmar In vitro reflux resistance in alginate rafts Gut 48 2001 A26
8. 111In-labeled alginate to study the pH dependence of alginic acid anti-esophageal reflux barrier Nucl. Med. Biol. 15 1988 563 571
9. J.R. Lambert, M.G. Korman, L. Nicholson, and J.G. Chan In vivo anti-reflux and raft properties of alginates Aliment. Pharmacol. Therap. 4 1990 615 622
10. ®) in the treatment of heartburn during pregnancy Int. J. Clin. Pract. 57 2003 175 179
11. L. Marciani, S.L. Little, J. Snee, N.S. Coleman, D.J. Tyler, J. Sykes, I.G. Jolliffe, P.W. Dettmar, R.C. Spiller, and P.A. Gowland Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in vivo J. Pharm. Pharmacol. 54 2002 1351 1356
12. H.A. May, C.G. Wilson, and J.G. Hardy Monitoring radiolabeled antacid preparations in the stomach Int. J. Pharm. 170 1984 169 176
13. R.K. Mittal, R.H. Holloway, R. Penagini, L.A. Blackshaw, and J. Dent Transient lower esophageal sphincter relaxation Gastoenterology 109 1995 601 610
14. S. Moe, K. Draget, G. Skjak-Braek, and O. Smidsrod A.M. Stephen Food Polysaccharides and their Applications 1995 Marcel Dekker New York 245 286
15. R.S. Paterson, B. O'Mahony, G.M. Eccleston, H.N.E. Stevens, J. Foster, and J.G. Murray An assessment of floating raft formation in man using magnetic resonance imaging J. Pharm. Pharmcol. 52 2000 8
16. T. Poynard and a French Co-operative Study Group Relapse rate of patients after healing of oesophagitis - a prospective study of alginate as self-care treatment for 6 months Aliment. Pharmacol. Therap. 7 1993 385 392
17. J. Vatier, C. Celice-Pingaud, and R. Farinotti A computerised artificial stomach model to assess sodium alginate-induced pH gradient Int. J. Pharm. 163 1998 225 229
18. N. Washington, C.G. Wilson, and S.S. Davis Evaluation of 'raft-forming' antacid neutralising capacity Int. J. Pharm. 27 1985 279 286
19. N. Washington, C. Washington, C.G. Wilson, and S.S. Davis What is 'Liquid Gaviscon'? A comparison of four international formulations Int. J. Pharm. 34 1986 105 109
20. N. Washington, C. Washington, C.G. Wilson, and S.S. Davis The effect of inclusion of aluminium hydroxide in alginate-containing raft-forming antacids Int. J. Pharm. 28 1986 139 143
21. N. Washington, C. Washington, and C.G. Wilson Gastric distribution and residence time of two anti-reflux formulations Int. J. Pharm. 39 1987 163 171
22. N. Washington, C.G. Wilson, D.L. Williams, and C. Robertson An investigation into the effect of cimetidine pre-treatment on raft formation of an anti-reflux agent Aliment. Pharmacol. Therap. 7 1993 553 559
23. N. Washington, J.S. Bell, G. Lamont, C.G. Wilson, and Toselli An investigation into the raft-forming properties of Topaal Whip, a novel anti-reflux agent, in healthy volunteers STP Pharm. Sci. 8 1998 123 126
24. N. Washington, M.A. Parker, and R.J.C. Steele Time to onset of action of sodium alginate, ranitidine, omeprazole and water based on oesophageal pH Gastroenterology 116 1999 A350
25. Withington, R., 1978. Pharmaceutical compositions for use in the suppression of gastric reflux. UK Patent GB 1 524 740 A (13 September).